AI Analysis AI Analysis of INCY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add INCY to Watchlist?
Some Reasons Why To Add INCY:
  • High gross margin of 92.5%
  • Healthy interest coverage ratio of 620.6x
  • Low bankruptcy risk (Altman Z-Score: 9.94)
PDF

Incyte Corporation stock price ended at $115.09 on Wednesday, after gaining 0.183%
(Updated on Jul 15, 2026)

Buy or Hold candidate since Jun 22, 2026 Gain 11.03%

The Incyte Corporation stock price gained 0.183% on the last trading day (Wednesday, 15th Jul 2026), rising from $114.88 to $115.09. During the last trading day the stock fluctuated 4.41% from a day low at $110.91 to a day high of $115.80. The price has risen in 6 of the last 10 days and is up by 1.53% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 387 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $173.24 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.94% during the next 3 months and, with a 90% probability hold a price between $124.99 and $146.25 at the end of this 3-month period.

INCY Signals & Forecast

The Incyte Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $116.39. On a fall, the stock will find some support from the long-term average at approximately $106.56. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -2.89%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Incyte Corporation stock

Incyte Corporation finds support from accumulated volume at $113.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.89 between high and low, or 4.41%. For the last week, the stock has had daily average volatility of 2.75%.

Our recommended stop-loss: $109.74 (-4.65%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (INCY) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Incyte Corporation to open at $113.93, and during the day (based on 14 day Average True Range), to move between $113.31 and $116.87, which gives a possible trading interval of +/-$3.57 (+/-3.15%) up or down from last closing price. If Incyte Corporation takes out the full calculated possible swing range there will be an estimated 3.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $113.75 (1.16%) than the resistance at $116.71 (1.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Incyte Corporation stock A Buy?

Incyte Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.176 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 16, 2026 - $113.93 ( 1.01%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

INCY Performance

Trading levels for INCY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 118.82 3.24%
R2 116.96 1.62%
R1 115.80 0.618%
Price 115.09
S1 112.07 -2.63%
S2 110.91 -3.63%
S3 109.04 -5.25%

Accumulated Volume Support & Resistance Levels

Level Price
R3 117.26 1.89%
R2 116.86 1.54%
R1 116.71 1.41%
Price 115.09
S1 113.75 -1.16%
S2 98.22 -14.66%
S3 96.74 -15.94%

FAQ

What is the symbol for Incyte Corporation Stock and on which exchange is it traded?
The symbol for Incyte Corporation is INCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Incyte Corporation Stock?
Incyte Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Incyte Corporation Stock?
Incyte Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Incyte Corporation Stock.

What's the current price of Incyte Corporation Stock?
As of the end of day on the Jul 15, 2026, the price of an Incyte Corporation (INCY) share was $115.09.

What is the 52-week high and low for Incyte Corporation Stock?
The 52-week high for Incyte Corporation Stock is $118.97 and the 52-week low is $67.17.

What is the market capitalization of Incyte Corporation Stock?
As of the Jul 15, 2026, the market capitalization of Incyte Corporation is 22.993B.

When is the next earnings date for Incyte Corporation?
The upcoming earnings date for Incyte Corporation is Jul 28, 2026.
Click to get the best stock tips daily for free!
ABOUT INCYTE CORPORATION
Incyte
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
4.04% Jul 13
SRPT
$17.02
3.47% Jun 29
NMRK
$15.02
3.26% Jun 24
JLL
$299.78
9.38% Jun 24
NESR
$25.07
15.24% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE